THE EFFECT OF ACTIVE SUBSTANCES IN THE PATISSON PLANT ON COLORECTAL CANCER

Authors

  • Yunusov Muhammadabror Abdumannob ugli Department of Biological Chemistry, Andijan State Medical Institute, Andijan, Uzbekistan Author

Keywords:

Colorectal cancer, patisson, Cucurbita pepo, cucurbitacin, apoptosis, phytochemicals, oncology, dietary prevention, signal transduction, cell viability.

Abstract

Colorectal cancer represents one of the most prevalent and lethal malignancies affecting the global population today. The severe adverse effects and growing chemoresistance associated with standard chemotherapeutic regimens have driven the scientific community to explore natural, plant-based alternatives. This research comprehensively investigates the antineoplastic properties of the active phytochemicals found in the patisson plant, scientifically known as Cucurbita pepo variety patissonina, specifically targeting human colorectal cancer cell lines. By utilizing a rigorous in vitro experimental design, the study evaluates the cytotoxic, anti-proliferative, and apoptosis-inducing effects of patisson extracts rich in cucurbitacins and polyphenols. The integrated literature review explores the biochemical nature of tetracyclic triterpenoids and their established capacity to disrupt crucial oncogenic signaling pathways. Empirical results from the cellular assays demonstrate that patisson extracts exert a profound, dose-dependent inhibitory effect on the viability of colon cancer cells. The mechanism of action is largely attributed to the suppression of the signal transducer and activator of transcription 3 pathway, which subsequently downregulates anti-apoptotic proteins and triggers the intrinsic mitochondrial apoptosis cascade. The discussion contextualizes these molecular findings within the broader framework of dietary chemoprevention, highlighting the synergistic benefits of the plant's high dietary fiber, antioxidant vitamins, and potent triterpenoids. Ultimately, the study concludes that the patisson plant is a highly valuable functional food and a promising source of lead compounds for the development of novel, targeted adjuvant therapies against colorectal malignancies.

References

1.Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394-424.

2.Garg, A. K., Buchholz, T. A., & Aggarwal, B. B. (2005). Chemosensitization and radiosensitization of tumors by plant polyphenols. Antioxidants & Redox Signaling, 7(11-12), 1630-1647.

3.Chen, J. C., Chiu, M. H., Nie, R. L., Cordell, G. A., & Qiu, S. X. (2005). Cucurbitacins and cucurbitane glycosides: structures and biological activities. Natural Product Reports, 22(3), 386-399.

4.Lee, D. H., Iwanski, G. B., & Thoennissen, N. H. (2010). Cucurbitacin: ancient compound shedding new light on cancer treatment. The Scientific World Journal, 10, 413-418.

5.Blaskovich, M. A., Sun, J., Cantor, A., Turkson, J., Jove, R., & Sebti, S. M. (2003). Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Cancer Research, 63(5), 1270-1279.

6.Thoennissen, N. H., Iwanski, G. B., Doan, N. B., Okamoto, R., Lin, P., Abbassi, S., ... & Koeffler, H. P. (2009). Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells. Cancer Research, 69(14), 5876-5884.

7.Bowman, T., Garcia, R., Turkson, J., & Jove, R. (2000). STATs in oncogenesis. Oncogene, 60(4), 5013-5022.

8.Dong, Y., Lu, B., Zhang, X., Zhang, J., Lai, L., Li, D., ... & Pang, X. (2010). Cucurbitacin E, a tetracyclic triterpenes compound from Chinese medicine, inhibits tumor angiogenesis through VEGFR2-mediated Jak2-STAT3 signaling pathway. Carcinogenesis, 70(16), 6393-6401.

9.Slattery, M. L., Boucher, K. M., Caan, B. J., Potter, J. D., & Ma, K. N. (1998). Eating patterns and risk of colon cancer. American Journal of Epidemiology, 148(1), 4-16.

10.Bingham, S. A., Day, N. E., Luben, R., Ferrari, P., Slimani, N., Norat, T., ... & Riboli, E. (2003). Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. The Lancet, 361(9368), 1496-1501.

11.Hamer, H. M., Jonkers, D., Venema, K., Vanhoutvin, S., Troost, F. J., & Brummer, R. J. (2008). Review article: the role of butyrate on colonic function. Alimentary Pharmacology & Therapeutics, 27(2), 104-119.

12.Aune, D., Chan, D. S., Lau, R., Vieira, R., Greenwood, D. C., Kampman, E., & Norat, T. (2011). Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies. BMJ, 343, d6617.

Downloads

Published

2026-08-28